找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Epidemiologic Research on Real-World Medical Data in Japan; Volume 2 Naoki Nakashima Book 2022 The Editor(s) (if applicable) and The Author

[復(fù)制鏈接]
樓主: ARGOT
11#
發(fā)表于 2025-3-23 11:35:51 | 只看該作者
So gesund, wie ein kleines Steak...,In Standardized Structured Medical Information eXchange 2 (SS-MIX2), the standard contract in Electronic Data Capture (EDC) of Japan, HOT code is specified as the standard code of drug.
12#
發(fā)表于 2025-3-23 16:20:40 | 只看該作者
13#
發(fā)表于 2025-3-23 20:02:15 | 只看該作者
Lindy Clemson,Jo Munro,Clemens BeckerWhen using data from medical records, disease conditions and patient information that are not clearly described must be determined. For example, even if the clinical information for the medical treatment fee is accurately described in the administrative claims data, it does not always precisely indicate the medical condition of a patient.
14#
發(fā)表于 2025-3-24 01:31:15 | 只看該作者
15#
發(fā)表于 2025-3-24 04:24:57 | 只看該作者
Wilfried J. Elspass,Manfred Flemming em.The mainstream of clinical research designs has been the . (RCT). In an RCT, two or more distinct interventions are randomly assigned to participating patients who have met strict eligibility criteria, with the patients’ outcomes followed-up and compared between the intervention groups.
16#
發(fā)表于 2025-3-24 08:26:44 | 只看該作者
17#
發(fā)表于 2025-3-24 12:05:34 | 只看該作者
Real World Medical Data and Clinical Pathway in JapanClinical pathways (CP) were developed by Karen Zander et al. in the 1980s. CP were epoch-making in the sense that traditional critical pathways used in engineering were applied to medical treatment.
18#
發(fā)表于 2025-3-24 15:34:38 | 只看該作者
19#
發(fā)表于 2025-3-24 19:00:51 | 只看該作者
20#
發(fā)表于 2025-3-25 02:22:53 | 只看該作者
Data Quality Governance Experience at the MID-NET ProjectRecently, with the widespread implementation of “Real-World Data (RWD),” there is increasing interest in using high-quality administrative claims, laboratory tests, electronic health records (EHRs), and information-sharing resources to enhance detection of serious adverse drug reactions (ADRs).
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 14:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
绥德县| 农安县| 中西区| 丁青县| 北票市| 唐海县| 靖宇县| 尖扎县| 渭源县| 株洲县| 郑州市| 镇宁| 都江堰市| 革吉县| 铜鼓县| 双城市| 布尔津县| 金沙县| 福州市| 阿瓦提县| 吉隆县| 罗源县| 西乌| 海安县| 元阳县| 宁安市| 甘孜县| 伊金霍洛旗| 天水市| 咸宁市| 宁南县| 钦州市| 华亭县| 孟连| 友谊县| 桃源县| 马尔康县| 眉山市| 阿城市| 荆门市| 蒙自县|